Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: An international multicenter prospective study

Circulation

Volumn 112, Issue 7, 2005, Pages 946-953

  Sadoul, Nicolas ^a   Mletzko, Ralph ^f   Anselme, Frédéric ^b   Bowes, Robert ^h   Schöls, Wolfgang ^g   Kouakam, Claude ^c   Casteigneau, Gaëlle ^d   Luise, Raffaele ⁱ   Iscolo, Nicolas ^e   Aliot, Etienne ^a  

^a CHU NANCY BRABOIS   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CHU RANGUEIL   (France)

^e and Le Plessis Robinson   (France)

^f Herz Kreislaufklinik Bevensen   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h NORTHERN GENERAL HOSPITAL   (United Kingdom)

ⁱ SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Arrhythmia; Defibrillation; Tachyarrhythmias; Tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFIBRILLATOR; DIZZINESS; FEMALE; FOLLOW UP; HEART PACING; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; IMPLANT; INCIDENCE; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 23844552454     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.533513     Document Type: Article

References (21)

1. Zaim BR, Zaim SH, Rankin AC, McGovern BA, Garan H, Ruskin JN, et al. Comparison of cycle lengths between induced and spontaneous sustained ventricular tachycardia during concordant antiarrhythmic therapy associated with healed myocardial infarction. Am J Cardiol. 1996;77:2-4.
2. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, Vlahakes GJ, Garan H, Ruskin JN. Limitations and complications of third-generation automatic cardioverter- defibrillators. Circulation. 1995;91:2204-2213.
3. Bänsch D, Castrucci M, Böcker D, Breithardt G, Block M. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance. J Am Coll Cardiol. 2000;36:557-565.
4. Weber M, Böcker D, Bänsch D, Brunn J, Castrucci M, Gradaus R, Breithardt G, Block M. Efficacy and safety of the initial use of stability and onset in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 1999;10:145-153.
5. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol. 1998;9:261-268.
6. Duru F, Bauersfeld U, Rahn-Schönbeck M, Candinas R. Morphology discriminator feature for enhanced ventricular tachycardia discrimination in implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2000;23:1365-1374.
7. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002;13:1092-1097.
8. Swerdlow CD, Schöls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD, for the Worldwide Jewel AF Investigators. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter defibrillator. Circulation. 2000;101:878-895.
9. Willkoff BL, Kühlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM. Critical analysis of dual chamber implantable cardioverter-defibrillator arrhythmia detection. Results and technical considerations. Circulation. 2001;103:381-386.
10. Sadoul N, Jung W, Jordaens L, Leenhardt A, Santini M, Wolpert C, Aliot E, for the Defender I and II Clinical Trials Investigators. Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective multicenter study. J Cardiovasc Electrophysiol. 2002;13:25-32.
11. Bailin SJ, Niebauer M, Tomassoni G, Leman R, for the Photon Investigators. Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003;14:144-149.
12. Kouakam C, Kacet S, Hazard JR, Ferraci A, Mansour H, Defaye P, Davy JM, Lambiez M, for the Ventak AV Investigators. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia. Europace. 2004;6:32-42.
13. Sinha AM, Stellbrink C, Schuchert A, Mox B, Jordaens L, Lamaison D, Gill J, Kaplan A, Merkely B, for the Phylax AV Investigator Group. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol. 2004;15:646-652.
14. Mletzko R, Aliot E, Seidl K, Lavergne T, Mabo P, Hohnloser S, Bocker D, Schoels W, Sadoul N. Safety and efficacy of a dual chamber implantable cardioverter defibrillator capable of slow ventricular tachycardia discrimination: a randomized study. Pacing Clin Electrophysiol. 2003;26:2275-2282.
15. Hauer RNW, Aliot E, Block M, Capucci A, Luderitz B, Santini M, Vardas PE, for the Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Indications for implantable cardioverter defibrillator (ICD) therapy. Eur Heart J. 2001;22:1074-1081.
16. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ, Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner TJ, Lewis RP, O'Rourke RA, Ryan TJ, Carson A Jr. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-1209.
17. Mletzko R, Anselme F, Klug D, Schoels W, Bowes R, Iscolo N, Nitzsche R, Sadoul N, for the Slow VT Study Investigators. Enhanced specificity of a dual chamber detection algorithm by rate stability criteria. Pacing Clin Electrophysiol 2004;27:1113-1119.
18. de Chillou C, Lacroix D, Klug D, Magnin-Poull I, Marquie C, Messier M, Andronache M, Kouakam C, Sadoul N, Chen J, Aliot E, Kacet S. Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation. 2002;105:726-731.
19. Rector RS, Kubo SH, Cohn JN. Patient's self assessment of their congestive heart failure. II: content, reliability, and validity of a new measure: the Minnesota Living With Heart Failure Questionnaire. Heart Fail. 1987;3:198-209.
20. Rector RS, Kubo SH, Cohn JN. Validity of the Minnesota Living With Heart Failure Questionnaire as a measure to therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106-1107.
21. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical ATP versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591-2596.